# Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

> **NCT03359642** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 23 (actual)

## Conditions studied

- Spondyloarthritis
- Crohn Disease
- Ulcerative Colitis

## Interventions

- **OTHER:** blood sample
- **OTHER:** stool samples
- **OTHER:** food questionnaire
- **OTHER:** colonoscopy
- **OTHER:** VOCs profile

## Key facts

- **NCT ID:** NCT03359642
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2021-09-16
- **Final completion:** 2021-09-16
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359642, "Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03359642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*